
|Videos|January 23, 2017
Ovarian Cancer: Enrolling in Clinical Trials
Advertisement
Advertisement
Related to this article

Six years after being diagnosed with B-cell ALL at 21, William Yank opens up about the physical changes of treatment, the emotional weight of constant care and the role hope plays in his survivorship.

Long-term results presented at ASTRO 2026 show that a shorter radiation schedule after mastectomy controls high-risk breast cancer as well as the standard five-week course, without more long-term side effects.

FDA fast-tracks review of elinzanetant for hot flashes linked to breast cancer treatment. Here’s what the trial found and what patients should know.

After two relapses, CAR T-cell therapy and a stem cell transplant, William Yank is in remission. But infertility, mental health challenges and a changed sense of self followed him into survivorship.

A phase 3 trial found proton therapy did not help people with advanced liver cancer live longer than standard photon radiation therapy.

A breast surgeon explains how rebuilding the breast with a person's own tissue and new tools may boost satisfaction and cut repeat surgery.

Some patients with lymphoma show no detectable cancer by day 8 of treatment, and a lymphoma specialist explains how early testing could guide care.
Advertisement
Advertisement
Trending on CURE
1
Hot Flashes From Breast Cancer Treatment May Soon Have an FDA-Approved Fix
2
Six Years After Leukemia, He Is Rebuilding the Life Cancer Changed at 21
3
Zenbexus Combo Nearly Doubles Deep Responses in Relapsed Myeloma
4
Why Early Response Testing Could Reshape Lymphoma Treatment
5



